Overview
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 110 days early.
- 202526/03/2026
- 202417/03/2025
- 202314/03/2024
- 202224/03/2023
- 202110/05/2022
- 202011/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
For making declarations of will and signing on behalf of the company, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Barbara Ewa Filipiukage 79 | 30 | $7,867.91 | 12.2449% |
Jarosław Zbigniew Filipiukage 54 | 31 | $8,130.17 | 12.6531% |
Zbigniew Franciszek Filipiukage 83 | 124 | $32,520.69 | 50.6122% |
Others | 60 | $15,735.82 | 24.4898% |
Zbigniew Franciszek Filipiuk, Jarosław Zbigniew Filipiuk and Barbara Ewa Filipiuk hold a combined 75.5% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-12-31.
55 1030 0019 0109 8503 0014 3716
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 72,207PLN 72,207 |
Public aid
4 public aid cases recorded, with a total value of $45,902.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,302$2,302 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,219$2,219 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 2, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $39,079$39,079 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Novartis Polandsp. z o.o. | $230,747,655.74 | novartis.com | ||
| Brandexsp. z o.o. | $1,958,619.75 | brandex.pl | ||
| PUBE Globalsp. z o.o. | $1,777,827.09 | pubeglobal.com | ||
| Tricopat Globalsp. z o.o. | $1,772,824.41 | tricopatglobal.com | ||
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com | ||
| Dental Solutionssp. z o.o. | $611,683.37 | dentalsolutions.pl | ||
| Beauty Care Solutionsp. z o.o. | $391,209.94 | ohhira.pl | ||
| Mitramed Paweł Wysocki, Piotr Wachaczyksp. j. | $198,282.96 | e.pl |
FAQ
Last updated: 2026-05-26